Expertise in
5
conditions

Dr. William H. Holderman

Washington Gastroenterology PLLC
Tacoma, WA
Expertise in
5
conditions
Specialties:Gastroenterology
Accepting New Patients
Offers Telehealth
Expertise in
5
conditions
OverviewInsuranceLocationsClinical Research

Overview

William Holderman is a Gastroenterologist in Tacoma, Washington. Dr. Holderman is highly rated in 5 conditions, according to our data. His top areas of expertise are Diarrhea, Trichohepatoenteric Syndrome, Crohn's Disease, Colonoscopy, and Gastrectomy. Dr. Holderman is currently accepting new patients.

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in WA
Hospital Affiliations
Tacoma General Allenmore Hospital
Languages Spoken
English
Castilian
Filipino
Hindi
Korean
Polish
Spanish
Telugu
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  PacificSource
  •  Premera
  •  Humana

Locations

WASHINGTON GASTROENTEROLOGY PLLC
2202 S Cedar St, Suite 330, Tacoma, WA 98405
253-272-5127

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of IMU-838 for Induction and Maintenance Therapy in Moderate-to-severe Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of IMU-838 for Induction and Maintenance Therapy in Moderate-to-severe Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: March 05, 2024
Intervention Type: Drug
Study Drug: IMU-838
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Expertise in
22
conditions
Dr. Kris Kowdley
Gastroenterology
Expertise in
22
conditions
Dr. Kris Kowdley
Gastroenterology
3216 Ne 45th Pl, Suite 212, 
Seattle, WA 
 (30.5 mi)
206-536-3030
Experience:
40+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kris Kowdley is a Gastroenterologist in Seattle, Washington. Dr. Kowdley has been practicing medicine for over 40 years is highly rated in 22 conditions, according to our data. His top areas of expertise are Primary Biliary Cholangitis, Cholangitis, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Colonoscopy.

Expertise in
54
conditions
Dr. Shayan S. Irani
Gastroenterology
Expertise in
54
conditions
Dr. Shayan S. Irani
Gastroenterology

Virginia Mason Medical Center

4575 Sand Point Way Ne, Suite 108, 
Seattle, WA 
 (30.7 mi)
206-525-8000
Languages Spoken:
English, Afrikaans, Filipino, Mandarin, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Shayan Irani is a Gastroenterologist in Seattle, Washington. Dr. Irani is highly rated in 54 conditions, according to our data. His top areas of expertise are Cholecystitis, Gallbladder Disease, Gastrointestinal Fistula, Endoscopy, and Gastric Bypass. Dr. Irani is currently accepting new patients.

Expertise in
44
conditions
Dr. Andrew S. Ross
Gastroenterology
Expertise in
44
conditions
Dr. Andrew S. Ross
Gastroenterology

Virginia Mason Medical Center

33501 1st Way S, 
Federal Way, WA 
 (8.1 mi)
253-838-2400
Languages Spoken:
English, Castilian, Czech, Japanese, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Ross is a Gastroenterologist in Federal Way, Washington. Dr. Ross is highly rated in 44 conditions, according to our data. His top areas of expertise are Barrett Esophagus, Hereditary Pancreatitis, Acute Pancreatitis, Endoscopy, and Colonoscopy. Dr. Ross is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile